For laboratory research use only. Not for human consumption. Not for clinical or therapeutic use. Not evaluated by the FDA.
For laboratory research use only. Not for human consumption. Not for clinical or therapeutic use. Not evaluated by the FDA.
Research Comparison
MOTS-c and NAD+ are both central to metabolic research but differ fundamentally. MOTS-c is a mitochondrial-derived signaling peptide studied for AMPK activation, while NAD+ is a coenzyme studied for mitochondrial function, sirtuin activation, and DNA repair.
| Attribute | MOTS-c | NAD+ |
|---|---|---|
| Type | Signaling peptide | Coenzyme / dinucleotide |
| Key pathway | AMPK activation | Sirtuin activation, PARP-1 |
| Research focus | Metabolic regulation, exercise mimetic | Mitochondrial function, aging |
They intersect in mitochondrial metabolism but act differently — MOTS-c is a peptide that activates AMPK signaling, whereas NAD+ is a coenzyme central to sirtuin activity and DNA repair.